This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Background The COVID-19 pandemic necessitated major reallocation of healthcare services. Our aim was to assess the impact on paediatric congenital heart disease (CHD) procedures during different pandemic periods compared with the prepandemic period, to inform appropriate responses to future major health services disruptions.
Objectives This study sought to evaluate the recovery of cardiovascular testing in Asia 1 year into the COVID-19 pandemic. Cardiovascular testing volumes in Asia decreased by 53% from March 2019 to April 2020, then recovered 96% of this decrease by April 2021, compared with 98% recovery in the rest of the world.
survival rates from out-of-hospital cardiac arrests fell significantly at the beginning of the COVID-19 pandemic in 2020 and only slightly. This news release contains updated information and data not included in the abstract. Research Highlights: U.S.
Out-of-hospital cardiac arrest survival rates dropped significantly at the onset of the COVID-19 pandemic in 2020 and have continued to remain lower than in the pre-pandemic years of 2015–2019, according to a preliminary study to be presented at the American Heart Association's Scientific Sessions 2024.,
The sociodemographic characteristics of patients undergoing intervention for aortic stenosis (AS) in England, and the impact of COVID-19, is unknown. Rates of SAVR declined during COVID-19 for all groups, but TAVI rates increased steadily. Results Of 179 645 procedures, there were 139 990 SAVR (mean age 71±10.8
Background It is unclear how COVID-19 pandemic affected care and outcomes among patients who are diagnosed with ST-elevation myocardial infarction (STEMI) in the USA. reduction in admissions in 2020. reduction in admissions in 2020. In 2020, 3.0% 12.55, P < 0.001) with COVID-19 infection compared with no infection.
BackgroundRecently, the use of telemedicine technology has increased due to the Covid-19 pandemic. This study aimed to identify the applications of telemedicine for cardiovascular diseases management during the Covid-19 pandemic.MethodsThis scoping study was conducted in 2023.
Objective To assess the feasibility, efficacy and safety of performing exercise stress echocardiography (ESE) for the assessment of myocardial ischaemia during the COVID-19 pandemic. Of the 17 healthcare professionals performing ESE, none contracted COVID-19 during this period. SE service performance increased to 96.8%
Objectives (1) To evaluate the prevalence and hospitalisation rate of COVID-19 infections among patients with dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM) in the Royal Brompton and Harefield Hospital Cardiovascular Research Centre (RBHH CRC) Biobank. (2) of the cardiomyopathy cohort reporting COVID-19 symptoms.
Background Acute myocardial infarction (AMI) is one of the most lethal complications of COVID-19 hospitalization. In this study, we looked for the occurrence of AMI and its effects on hospital outcomes among COVID-19 patients. Methods Data from the 2020 California State Inpatient Database was used retrospectively.
Objective To identify the most common transthoracic echocardiogram (TTE) parameters in patients hospitalised with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2/COVID-19) and their association with myocardial injury and outcomes. Moreover, COVID-19-induced myocarditis remains extremely rare.
Background We sought to examine a 1-year incidence of atrial fibrillation (AF) among patients with SARS-CoV-2 virus (COVID-19) in comparison to those with non-COVID-19 acute upper respiratory infection (AURI). Similar findings were observed for the COVID-19 (n=169 687) versus AURI prepandemic (n=169 486) comparison (2.7%
Prateek Bhatnagar, Director Cardiac Surgery & Chief Cardiology Surgeon at Care Hospital, Banjara Hills, Hyderabad, has successfully operated & discharged India’s first post Covid19 recovered patient who on 16th July, 2020, underwent a triple bypass surgery under Dr. Bhatnagar & his team of doctors here.
The current pandemic of a new coronavirus infection, which began in March 2020, was marked by an increase in cardiovascular diseases, including an increase in the number of patients with AF. However, most research in this area has focused on hospital patients.
Aims We evaluated the effects of the COVID-19 pandemic on hospital admission and quality of care for acute coronary syndrome. Data were fitted to segmented regression models with March 2020 as the breakpoint. In patients with STEMI, the pandemic did not affect reperfusion rates (0.29%, (95% CI) –1.5%
Myopericarditis is a now a well reported complication associated with Sars-Cov-2 (COVID-19) vaccinations. To add insult to injury, he contracted COVID 2 months after the second episode of pericarditis, but had no recurrence of the symptoms of pericarditis. The tragedy here is that this wasn’t a surprise.
Background The COVID-19 pandemic disrupted cardiovascular disease management in primary care in England. OpenSAFELY can be used to continuously monitor changes in national quality-of-care schemes to identify changes in key clinical subgroups early and support prioritisation of recovery from care disrupted by COVID-19.
Background:The COVID-19 pandemic has significantly exacerbated sleep problems. Changes in daily life due to COVID-19 were assessed by asking participants to score their current situation compared to their pre-pandemic situation, ranging from 100 (no change) to 0 (complete cessation of daily activities).
BackgroundPatients with ischemic stroke and concomitant COVID‐19 infection have worse outcomes than those without this infection, but the impact of COVID‐19 on hemorrhagic stroke remains unclear. We aimed to assess if COVID‐19 worsens outcomes in intracerebral hemorrhage (ICH).Methods
Background:Hemorrhagic cerebrovascular manifestations are known to be associated with COVID-19. Comparative outcome analyses between pre-COVID (2016-2019) and COVID year (2020) were performed. Comparative outcome analyses between pre-COVID (2016-2019) and COVID year (2020) were performed.
Background:Different from the negative impact of COVID-19 pandemic on outcomes after out-of-hospital cardiac arrest (OHCA) collapsed before emergency medical service (EMS) arrival, there was a report suggested that COVID-19 pandemic did not affect outcomes after OHCA witnessed by EMS personnel. to 1.07; p = 0.24).
BACKGROUND:The association of COVID-19 with higher bleeding risk and worse outcomes in acute ischemic stroke (AIS) undergoing revascularization may be related to the presence of infection symptoms. We compared COVID-negative controls, AS-COVID, and S-COVID using multivariable regression. 2.32], respectively).
Whether the COVID-19 pandemic impacted stroke etiology is still being investigated, but most studies have been performed outside the United States. Adults (18) with AIS were compared based on admission date: Pre-COVID period (1/1/2019 12/31/2019) vs. COVID period (3/1/2020 3/1/2021).
Background:Coronavirus disease 2019 (COVID-19) increases the risk of cerebral venous sinus thrombosis (CVST), and previous reports derived from small case series reported a high mortality in these patients, up to 40%. but there were fewer women in the COVID-CVST group (50% vs 68%,P<0.01).
IntroductionThe goal of this research project is to investigate the impacts and effects of the COVID‐19 pandemic on acute ischemic stroke treatment in North America. Among patients with an ischemic stroke, thrombectomy administration decreased by up to 25% in February 2020 compared to February 2019 (Zhao et al.,
The outbreak of COVID-19 pandemic was first reported in China between December 2019 and January 2020 and then spread to Europe, with Italy among the first countries with recognized clusters. The COVID-19 pandemic turned everyone’s life upside down and the end of the emergency was declared by WHO only on May 5, 2023.
Background:Severe COVID-19 infection has been associated with acute respiratory distress syndrome (ARDS) and right ventricular (RV) dysfunction. A retrospective chart review was performed on 41 patients with COVID-19 on ECMO between March and October 2020.
Telehealth visits increased during the COVID-19 pandemic, with a peak in April 2020. About half of primary care visits were telehealth, but the percentage declined and stabilized to about 8% in late 2021.
Background:It is still not well understood whether cardiac injury observed during acute COVID-19 infection extends after recovery from the initial viral infection. from March 2020 to October 2021. Adult patients were identified by hospitalizations using ICD-10 code U07.1
Background:Nationwide data demonstrating the impact of the COVID-19 pandemic on hemorrhagic stroke outcomes are lacking.Methods:We used the National Inpatient Sample (2016-2020) to identify adults (>=18 years) with primary intracerebral hemorrhage (ICH) or subarachnoid hemorrhage (SAH). 2.51; SAH: 2.76, 1.68-4.54),
With decreases in stroke admission across Latin America during COVID‐19, it is evident that the pandemic has negatively impacted hospitals’ abilities to manage as many stroke cases as before (Pujol‐Lereis et al., Additional questions revolved around urban/rural disparities in care and potential solutions (Hammond et al.,
It goes without saying that 2020 presented many challenges for the worldwide EM community. As we enter 2021 I thought it important to reflect on what we did well in 2020, what made us proud to be EM docs, so that we keep this perspective and keep on growing as a community going forward. And this is what they said….
Background Patients with cardiovascular disease (CVD) and risk factors have increased rates of adverse events and mortality after hospitalization for coronavirus disease 2019 (COVID-19). In this study, we attempted to identify and assess the effects of CVD on COVID-19 hospitalizations in the USA using a large national database.
The system is decentralized with 19 regions and two autonomous provinces responsible for the delivery of health services through Local Health Units (ASLs). years, which has recovered well following a large decline due to COVID in 2020. In terms of healthcare spending, Italy allocates about 9.4%
The ECG and long lead II rhythm strip in Figure-1 — was obtained from a COVID positive patient with persistent tachycardia not responding to Diltiazem. Applying the Above to Today's Case: In addition to being Covid-positive — the patient in today's case had longstanding COPD. How would YOU interpret this tracing?
Also discussed in this episode is how the COVID-19 pandemic has highlighted a gap between the worlds of science and communication; so it is more important than ever to consider social media to help create pathways, form collaborations, grab attention, and explain the science. gtrainyte Thu, 07/23/2020 - 08:22 Duration 31 min.
in 2020 (P<0.001) (Table). However, the exception was in 2020 where increased utilization of home health was accompanied by decreases in IRF and SNF discharge.Conclusions:We did not find clinically meaningful differences in discharge patterns between TM and MA populations. Changes in 2020 were likely attributed to COVID-19.
Literature retrieved using the above keywords and published were included with a time limit from 1st January 2020 to 8th Aug 2024.ResultsThe ResultsThe bibliometric analysis of COVID-19 and Sudden Cardiac Death highlights key research trends from 2020 to 2024, revealing a rapid surge in scientific output during the pandemic.
3) were treated with SARS-CoV-2 (Isolate USA-WA1/2020) or delta variant spike protein for 24h then later exposed to hypoxia for 6h (to model the effects of in vivo pulmonary infection). This approach may be pivotal in reducing both acute and chronic neurological morbidities associated with COVID-19.
Countries in the region of interest were categorized into three groups based on stroke and COVID‐19 data. Interns also developed interventions to address key barriers identified during the research.ResultsThe first cohort (2020) comprised 8 interns who investigated barriers to stroke treatment across different regions.
This survey, conducted in 2020 and predominantly among physicians, also revealed that the nature of the duties executed from home encompassed most clinical tasks. Sources: [link] Working from home during COVID-19 pandemic (ama-assn.org) [link] Would you like to learn more about how Cardiomatics is changing the daily routine of doctors?
Billion in 2020. Also Read : Comprehending the Dreadful Impacts of COVID-19 on Cardiovascular Treatments Nuclear Imaging Despite its several side effects, radiation therapy has benefited different types of neurological medical conditions and cancers.
Background Studies have shown an increased risk of cardiac disease following COVID-19, but how it compares to pneumonia of other etiologies is unclear. Aims To determine the incidence and HRs of cardiac disease in patients hospitalised with COVID-19 compared with other viral or bacterial pneumonias.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
81 
Let's personalize your content